• OTC Product News (September 2014)
  • Pharmacy Shopping for ADHD Medications Similar to Opioids
  • Psoriasis and Psoriatic Arthritis Patient Care: What Pharmacists Should Know
  • MTM Services Underused in Part D Drug Plans
  • Varicella-Zoster Virus: An Ounce of Prevention Does Not Equal a Cure

Breaking News

Pharmacists Positively Impact Diabetes Outcomes Through Collaborative Care Teams
Pharmacists who participate in community-based diabetes care teams play a pivotal role in reducing A1C levels among patients with poorly controlled diabetes.
The current Ebola epidemic is causing the health care system in West Africa to collapse.
Secukinumab improved peripheral joint disease, prevented joint damage, and produced clear or almost clear skin in a pair of pivotal Phase 3 trials.
Live medication therapy management (MTM) reduces low-density-lipoprotein cholesterol significantly more than standard, chart-review MTM.
A combination of vemurafenib (Zelboraf) and experimental drug cobimetinib significantly reduces the development of secondary skin cancer.
The dexamethasone intravitreal implant, Ozurdex, is now indicated to treat all patients with diabetic macular edema.
ADHD medications are prone to the same abuse, misuse, and diversion as opioids.

From the Issue

Previous TabNext Tab
Strategic Alliance Partners
Latest Issues